How many drugs treat Epithelioid sarcoma?

Drug Landscape tracks 2 marketed treatments for Epithelioid sarcoma (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/epithelioid-sarcoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Epithelioid sarcoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epithelioid sarcoma (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Epithelioid sarcoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Tazverik	tazemetostat	Epizyme Inc	Methyltransferase Inhibitor	Polycomb protein EED		2020-01-01
Tazverik	Tazverik	Edwin Posadas, MD		Polycomb protein EED, Histone-lysine N-methyltransferase EZH1, Histone-lysine N-methyltransferase EZH2

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Epizyme Inc · 2 drugs in Epithelioid sarcoma
Edwin Posadas, MD · 1 drug in Epithelioid sarcoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Epithelioid sarcoma:

Cite this brief

Drug Landscape (2026). Epithelioid sarcoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/epithelioid-sarcoma. Accessed 2026-06-10.

Epithelioid sarcoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing